UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Use of dual-energy X-ray absorptiometry (DXA) for diagnosis and fracture risk assessment; WHO-criteria, T- and Z-score, and reference databases

Bone (New York, N.Y.), 2017-11, Vol.104, p.39-43

Dimai, Hans P.

2017

Volltextzugriff (PDF)

Long-term and sequential treatment for osteoporosis

Nature reviews. Endocrinology, 2023-09, Vol.19 (9), p.520-533

2023

Volltextzugriff (PDF)

Osteoporosis and Fragility Fractures: currently available pharmacological options and future directions

Best practice & research. Clinical rheumatology, 2022-09, Vol.36 (3), p.101780-101780, Article 101780

2022

Volltextzugriff (PDF)

Association of Vitamin D Deficiency with Heart Failure and Sudden Cardiac Death in a Large Cross-Sectional Study of Patients Referred for Coronary Angiography

The journal of clinical endocrinology and metabolism, 2008-10, Vol.93 (10), p.3927-3935

2008

Volltextzugriff (PDF)

Automated Knee Osteoarthritis Assessment Increases Physicians’ Agreement Rate and Accuracy: Data from the Osteoarthritis Initiative

Cartilage, 2021-12, Vol.13 (1_suppl), p.957S-965S

2021

Volltextzugriff (PDF)

Clinicians should be aware of their responsibilities as role models: a case report on the impact of poor role modeling

Medical education online, 2014-01, Vol.19 (1), p.23479-23479

2014

Volltextzugriff (PDF)

Race-specific FRAX models are evidence-based and support equitable care: a response to the ASBMR Task Force report on Clinical Algorithms for Fracture Risk

Osteoporosis international, 2024-09, Vol.35 (9), p.1487-1496

2024

Volltextzugriff (PDF)

Osteoporosis treatment in Austria—assessment of FRAX-based intervention thresholds for high and very high fracture risk

Archives of osteoporosis, 2022-12, Vol.17 (1), p.141-141, Article 141

2022

Volltextzugriff (PDF)

Effect of eplerenone on markers of bone turnover in patients with primary hyperparathyroidism – The randomized, placebo-controlled EPATH trial

Bone (New York, N.Y.), 2017-12, Vol.105, p.212-217

2017

Volltextzugriff (PDF)

Have "new" methods in medical education reached German-speaking Central Europe: a survey

BMC medical education, 2014-08, Vol.14 (1), p.172-172, Article 172

2014

Volltextzugriff (PDF)

Plasma parathyroid hormone and cardiovascular disease in treatment‐naive patients with primary hyperparathyroidism: The EPATH trial

The journal of clinical hypertension (Greenwich, Conn.), 2017-11, Vol.19 (11), p.1173-1180

2017

Volltextzugriff (PDF)

Official Positions for FRAX® clinical regarding smoking from Joint Official Positions Development Conference of the International Society for Clinical Densitometry and International Osteoporosis Foundation on FRAX

Journal of clinical densitometry, 2011-07, Vol.14 (3), p.190

2011

Volltextzugriff (PDF)

Official Positions for FRAX® Clinical Regarding Smoking

Journal of clinical densitometry, 2011-07, Vol.14 (3), p.190-193

2011

Volltextzugriff (PDF)

Medical University admission test: a confirmatory factor analysis of the results

Wiener Klinische Wochenschrift, 2016-05, Vol.128 (9-10), p.376-383

2016

Volltextzugriff (PDF)

Vitamin D status and its relationship with bone mineral density and parathyroid hormone in Southeast Asian adults with low bone density

Endocrine practice, 2011-03, Vol.17 (2), p.226-234

2011

Volltextzugriff (PDF)

Use of d ual- e nergy X- r ay a bsorptiometry (DXA) for d iagnosis and f racture r isk a ssessment; WHO-criteria, T- and Z-score, and r eference d atabases

Bone (New York, N.Y.), 2016

Dimai, Hans P

2016

Volltextzugriff (PDF)

Bone Loss in Patients with Untreated Chronic Obstructive Pulmonary Disease Is Mediated by an Increase in Bone Resorption Associated with Hypercapnia

Journal of bone and mineral research, 2001-11, Vol.16 (11), p.2132-2141

2001

Volltextzugriff (PDF)

Reversal in the secular trend of hip fracture incidences in Austria

Wiener Klinische Wochenschrift, 2010-06, Vol.122 (11-12), p.380-381

2010

Volltextzugriff (PDF)

New considerations on the management of osteoporosis in Central and Eastern Europe (CEE): summary of the “3rd Summit on Osteoporosis—CEE”, November 2009, Budapest, Hungary

Archives of osteoporosis, 2011, Vol.6 (1-2), p.1-12

2011

Volltextzugriff (PDF)

284. A NOVEL COMBINATION OF BONE MICRO-ARCHITECTURE DESCRIPTORS FOR THE IDENTIFICATION OF OSTEOARTHRITIS

Rheumatology (Oxford, England), 2017-04, Vol.56 (suppl_2)

2017

Volltextzugriff (PDF)

Situational judgment test as an additional tool in a medical admission test: an observational investigation

BMC research notes, 2015-03, Vol.8 (1), p.81-81, Article 81

2015

Volltextzugriff (PDF)

Official Positions for FRAX® clinical regarding international differences from Joint Official Positions Development Conference of the International Society for Clinical Densitometry and International Osteoporosis Foundation on FRAX

Journal of clinical densitometry, 2011-07, Vol.14 (3), p.240-262

2011

Volltextzugriff (PDF)

Joint Official Positions of the International Society for Clinical Densitometry and International Osteoporosis Foundation on FRAX(®). Executive Summary of the 2010 Position Development Conference on Interpretation and use of FRAX® in clinical practice

Journal of clinical densitometry, 2011-07, Vol.14 (3), p.171-180

2011

Volltextzugriff (PDF)

Official Positions for FRAX® clinical regarding falls and frailty: can falls and frailty be used in FRAX®? From Joint Official Positions Development Conference of the International Society for Clinical Densitometry and International Osteoporosis Foundation on FRAX

Journal of clinical densitometry, 2011-07, Vol.14 (3), p.194-204

2011

Volltextzugriff (PDF)

Official Positions for FRAX(®) clinical regarding glucocorticoids: the impact of the use of glucocorticoids on the estimate by FRAX(®) of the 10 year risk of fracture from Joint Official Positions Development Conference of the International Society for Clinical Densitometry and International Osteoporosis Foundation on FRAX(®)

Journal of clinical densitometry, 2011-07, Vol.14 (3), p.212

2011

Volltextzugriff (PDF)

1 – 25 von 50

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(47)
Mit Volltextzugriff
(45)

Publikationsform

Artikel
(49)
Bücher
(1)

Sprache

Englisch
(49)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Use of dual-energy X-ray absorptiometry (DXA) for diagnosis and fracture risk assessment; WHO-criteria, T- and Z-score, and reference databases

Long-term and sequential treatment for osteoporosis

Osteoporosis and Fragility Fractures: currently available pharmacological options and future directions

Association of Vitamin D Deficiency with Heart Failure and Sudden Cardiac Death in a Large Cross-Sectional Study of Patients Referred for Coronary Angiography

Automated Knee Osteoarthritis Assessment Increases Physicians’ Agreement Rate and Accuracy: Data from the Osteoarthritis Initiative

Clinicians should be aware of their responsibilities as role models: a case report on the impact of poor role modeling

Race-specific FRAX models are evidence-based and support equitable care: a response to the ASBMR Task Force report on Clinical Algorithms for Fracture Risk

Osteoporosis treatment in Austria—assessment of FRAX-based intervention thresholds for high and very high fracture risk

Effect of eplerenone on markers of bone turnover in patients with primary hyperparathyroidism – The randomized, placebo-controlled EPATH trial

Have "new" methods in medical education reached German-speaking Central Europe: a survey

Plasma parathyroid hormone and cardiovascular disease in treatment‐naive patients with primary hyperparathyroidism: The EPATH trial

Official Positions for FRAX® clinical regarding smoking from Joint Official Positions Development Conference of the International Society for Clinical Densitometry and International Osteoporosis Foundation on FRAX

Official Positions for FRAX® Clinical Regarding Smoking

Medical University admission test: a confirmatory factor analysis of the results

Vitamin D status and its relationship with bone mineral density and parathyroid hormone in Southeast Asian adults with low bone density

Use of d ual- e nergy X- r ay a bsorptiometry (DXA) for d iagnosis and f racture r isk a ssessment; WHO-criteria, T- and Z-score, and r eference d atabases

Bone Loss in Patients with Untreated Chronic Obstructive Pulmonary Disease Is Mediated by an Increase in Bone Resorption Associated with Hypercapnia

Reversal in the secular trend of hip fracture incidences in Austria

New considerations on the management of osteoporosis in Central and Eastern Europe (CEE): summary of the “3rd Summit on Osteoporosis—CEE”, November 2009, Budapest, Hungary

284. A NOVEL COMBINATION OF BONE MICRO-ARCHITECTURE DESCRIPTORS FOR THE IDENTIFICATION OF OSTEOARTHRITIS

Situational judgment test as an additional tool in a medical admission test: an observational investigation

Official Positions for FRAX® clinical regarding international differences from Joint Official Positions Development Conference of the International Society for Clinical Densitometry and International Osteoporosis Foundation on FRAX

Joint Official Positions of the International Society for Clinical Densitometry and International Osteoporosis Foundation on FRAX(®). Executive Summary of the 2010 Position Development Conference on Interpretation and use of FRAX® in clinical practice

Official Positions for FRAX® clinical regarding falls and frailty: can falls and frailty be used in FRAX®? From Joint Official Positions Development Conference of the International Society for Clinical Densitometry and International Osteoporosis Foundation on FRAX

Suchergebnisse filtern